Quick Take: Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site
Gene expression profiling is a novel approach to identifying where cancers of unknown primary site (CUP) originate. Whether the use ...